# Moderna (MRNA) — News

MRNA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mrna/news

## Recent headlines

- [Moderna (MRNA) shares rose 5.28% in intraday trading after market anticipation of upcoming late-stage clinical trial data for its cancer vaccine, intismeran.](https://www.ainvest.com/news/moderna-mrna-shares-rose-5-28-intraday-trading-market-anticipation-upcoming-late-stage-clinical-trial-data-cancer-vaccine-intismeran-2610) — AInvest Wire, Oct 15, 2026
  Moderna (MRNA) shares rose 5.28% in intraday trading on October 15, 2026, as investors reacted to the biotechnology firm’s recent announcement regarding its experimental cancer vaccine, intismeran autogene. The vaccine, developed in collaboration with Merck (MRK), demonstrated 49% reduction in…
- [Vaccine Products stocks rose in regular trading, with MRNA up 6.46%, ZTS gaining 4.54% and BMY rising 3.71%.](https://www.ainvest.com/news/vaccine-products-stocks-rose-regular-trading-mrna-6-46-zts-gaining-4-54-bmy-rising-3-71-2610-4) — AInvest Wire, Oct 15, 2026
- [Moderna (MRNA) fell 5.2% in intraday trading after rising 14.2% on Friday, marking a reversal of the prior session's move.](https://www.ainvest.com/news/moderna-mrna-fell-5-2-intraday-trading-rising-14-2-friday-marking-reversal-prior-session-move-2610) — AInvest Wire, Oct 12, 2026
  Moderna Inc. (MRNA) experienced a 5.2% decline in intraday trading on Friday, reversing a 14.2% gain from the previous session. The sharp pullback has raised questions among investors about the sustainability of the recent rally and the factors influencing the stock’s volatility. Analysts have…
- [Vaccine Products stocks rose in regular trading, with Moderna up 8.98%, Illumina gaining 3.13% and ZTS rising 1.59%.](https://www.ainvest.com/news/vaccine-products-stocks-rose-regular-trading-moderna-8-98-illumina-gaining-3-13-zts-rising-1-59-2610-66) — AInvest Wire, Oct 9, 2026
- **Important** — [Moderna (MRNA.O): BofA global research raises price objective to $200 from $170](https://www.ainvest.com/news/moderna-mrna-bofa-global-research-raises-price-objective-200-170-2610) — AInvest Wire, Oct 9, 2026

## Similar Stocks

- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [NVAX](https://www.lighthorse.io/tickers/nvax) — Novavax, Inc. - Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [OCGN](https://www.lighthorse.io/tickers/ocgn) — Ocugen, Inc. - Common Stock
- [TSLA](https://www.lighthorse.io/tickers/tsla) — Tesla, Inc.  - Common Stock
- [REGN](https://www.lighthorse.io/tickers/regn) — Regeneron Pharmaceuticals, Inc. - Common Stock
- [HOOD](https://www.lighthorse.io/tickers/hood) — Robinhood Markets, Inc. - Class A Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).